The Prevalence Of The Drug Used By Patients With A History Of Minor Recurrent Aftose Stomatitis
The Prevalence of the Drug Used by Patients with a History of Minor Recurrent Aftose Stomatitis
Introduction
Recurrent Aftose Stomatitis (SAR) is a common condition that affects the oral cavity mucosa, and minor SAR is one of the most common types. Treatment for SAR is generally symptomatic, aiming to reduce pain, reduce the size and number of ulcers, and prevent recurrence. Various types of drugs are used in SAR treatment, including anti-inflammatory, antibiotics, antiseptic, topical corticosteroids, and systemic corticosteroids. This study aims to identify the type of drug and the form of drug preparations used by patients with a history of minor SAR, as well as knowing the length of healing in them.
Methodology
This study uses a descriptive method with a cross-sectional approach involving 106 respondents. The selection of samples was carried out using the non-probability purposive sampling method, with inclusion criteria being students who had a history of minor SAR and were willing to become respondents. Data is collected online through the Google Form, where respondents signed informed consent first, then fill in demographic data and history of drug use for SAR treatment.
Results
The results showed that the class of antiseptic drugs dominated the use, with 40 respondents (37.73%) using this category. The form of mouthwash is also the most widely used, with 35 respondents (33.02%). In addition, the most common healing time is less than 7 days, which was recorded in 67 respondents (63.20%).
Discussion
The prevalence of the use of antiseptic and mouthwash in minor SAR treatment indicates that dentists and other medical personnel prefer a relatively safe method and have a fast effect. Antiseptic drugs, such as Chlorhexidine, are known to be effective in killing bacteria and reducing inflammation, which are the main causes of pain and discomfort in SAR. The use of mouthwash also plays an important role in maintaining oral hygiene and accelerating the healing process by reducing bacteria in the Ulser area.
Conclusion
This study provides deeper insight regarding treatment preference among young patients who face this problem, as well as showing that with proper treatment, the duration of healing can be accelerated. As a recommendation, it is important for medical personnel to continue to increase education about minor SAR treatment and the use of appropriate drugs. This awareness will help patients understand the treatment they live and the potential to prevent recurrence in the future.
Recommendations for Future Research
This information is also useful for other researchers who will conduct further studies on the prevalence and effectiveness of SAR treatment. Further research can be conducted to explore the effectiveness of different types of antiseptic drugs and mouthwash in treating minor SAR. Additionally, studies can be conducted to investigate the relationship between the use of antiseptic drugs and mouthwash and the duration of healing in patients with minor SAR.
Implications for Clinical Practice
The findings of this study have implications for clinical practice. Dentists and other medical personnel should be aware of the prevalence of antiseptic and mouthwash use in minor SAR treatment and consider these options when treating patients with this condition. Additionally, patients should be educated about the use of antiseptic drugs and mouthwash in treating minor SAR and the potential benefits of these treatments.
Limitations of the Study
This study has several limitations. The sample size was relatively small, and the study was conducted using a non-probability sampling method. Additionally, the study only investigated the use of antiseptic drugs and mouthwash in treating minor SAR and did not explore other types of treatments. Future studies can be conducted to address these limitations and provide a more comprehensive understanding of the prevalence and effectiveness of SAR treatment.
Conclusion
In conclusion, this study provides a clearer understanding of the prevalence of drug use in patients with a history of minor recurrent aftose stomatitis as well as factors that can affect the results of healing. The findings of this study have implications for clinical practice and highlight the importance of education and awareness about minor SAR treatment and the use of appropriate drugs.
References
- [List of references cited in the study]
Appendix
- [Additional information or data that is not included in the main body of the study]
Abstract
This study aims to identify the type of drug and the form of drug preparations used by patients with a history of minor SAR, as well as knowing the length of healing in them. The results showed that the class of antiseptic drugs dominated the use, with 40 respondents (37.73%) using this category. The form of mouthwash is also the most widely used, with 35 respondents (33.02%). In addition, the most common healing time is less than 7 days, which was recorded in 67 respondents (63.20%). The findings of this study have implications for clinical practice and highlight the importance of education and awareness about minor SAR treatment and the use of appropriate drugs.
Frequently Asked Questions (FAQs) about the Prevalence of the Drug Used by Patients with a History of Minor Recurrent Aftose Stomatitis
Q: What is Recurrent Aftose Stomatitis (SAR)?
A: Recurrent Aftose Stomatitis (SAR) is a common condition that affects the oral cavity mucosa, and minor SAR is one of the most common types. It is characterized by the recurrence of ulcers in the mouth, which can be painful and uncomfortable.
Q: What are the common symptoms of SAR?
A: The common symptoms of SAR include pain, discomfort, and difficulty eating or speaking. The ulcers can also be accompanied by inflammation and redness in the affected area.
Q: What are the common treatments for SAR?
A: The common treatments for SAR include anti-inflammatory medications, antibiotics, antiseptic mouthwashes, topical corticosteroids, and systemic corticosteroids. The treatment aims to reduce pain, reduce the size and number of ulcers, and prevent recurrence.
Q: What is the most commonly used drug in treating SAR?
A: The most commonly used drug in treating SAR is antiseptic mouthwash, which is used by 35 respondents (33.02%) in this study. Antiseptic mouthwash is effective in killing bacteria and reducing inflammation, which are the main causes of pain and discomfort in SAR.
Q: What is the most common healing time for SAR?
A: The most common healing time for SAR is less than 7 days, which was recorded in 67 respondents (63.20%) in this study. This indicates that with proper treatment, the duration of healing can be accelerated.
Q: What are the implications of this study for clinical practice?
A: The findings of this study have implications for clinical practice. Dentists and other medical personnel should be aware of the prevalence of antiseptic and mouthwash use in minor SAR treatment and consider these options when treating patients with this condition. Additionally, patients should be educated about the use of antiseptic drugs and mouthwash in treating minor SAR and the potential benefits of these treatments.
Q: What are the limitations of this study?
A: This study has several limitations. The sample size was relatively small, and the study was conducted using a non-probability sampling method. Additionally, the study only investigated the use of antiseptic drugs and mouthwash in treating minor SAR and did not explore other types of treatments.
Q: What are the recommendations for future research?
A: Further research can be conducted to explore the effectiveness of different types of antiseptic drugs and mouthwash in treating minor SAR. Additionally, studies can be conducted to investigate the relationship between the use of antiseptic drugs and mouthwash and the duration of healing in patients with minor SAR.
Q: What are the implications of this study for patients with SAR?
A: The findings of this study highlight the importance of education and awareness about minor SAR treatment and the use of appropriate drugs. Patients with SAR should be aware of the potential benefits of antiseptic mouthwash and other treatments and should discuss their treatment options with their healthcare provider.
Q: How can patients with SAR manage their symptoms?
A: Patients with SAR can manage their symptoms by practicing good oral hygiene, avoiding irritants and allergens, and using antiseptic mouthwash and other treatments as recommended by their healthcare provider. Additionally, patients can try to reduce stress and anxiety, which can exacerbate symptoms of SAR.